Prosecution Insights
Last updated: April 19, 2026
Application No. 18/395,084

DRUG IDENTIFICATION APPARATUS, DRUG IDENTIFICATION METHOD AND PROGRAM

Non-Final OA §101
Filed
Dec 22, 2023
Examiner
CHEN, HUO LONG
Art Unit
2682
Tech Center
2600 — Communications
Assignee
Fujifilm Medical Co. Ltd.
OA Round
1 (Non-Final)
53%
Grant Probability
Moderate
1-2
OA Rounds
3y 2m
To Grant
84%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allow Rate
314 granted / 590 resolved
-8.8% vs TC avg
Strong +30% interview lift
Without
With
+30.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
37 currently pending
Career history
627
Total Applications
across all art units

Statute-Specific Performance

§101
11.3%
-28.7% vs TC avg
§103
64.3%
+24.3% vs TC avg
§102
12.5%
-27.5% vs TC avg
§112
8.1%
-31.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 590 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-14 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a Judicial Exception in the form of an Abstract Idea, without significantly more: Beginning with independent claim 1, an apparatus claim, which recites: A drug identification apparatus comprising: one or more processors; and one or more storage devices, wherein the one or more storage devices are configured to store an identification mark master including an image of an identification mark on each of a front surface and a back surface, for each drug having the identification mark formed by engraving or printing thereon, and wherein the one or more processors are configured to: detect each drug, from a first-surface image acquired by imaging a first surface of a package accommodating drugs in a packaging bag; create, from the identification mark master by using information on a determined drug which is at least one of the drugs, and whose drug type and a front surface and a back surface have been determined based on a drug image extracted for each drug from the first-surface image, a second-surface ground-truth identification mark image list including an identification mark image showing an identification mark of the determined drug appearing on a second surface being a back surface of the first surface of the package; detect each drugs from a second-surface image acquired by imaging the second surface of the package; extract an identification mark of each drug from the second-surface image, and create an extracted identification-mark image list including an extracted identification-mark image for each drug; determine the determined drug in the second-surface image by performing pattern matching using the second-surface ground-truth identification mark image list and the extracted identification-mark image list; and present on the second-surface image, information for differentiating the determined drug from a undetermined drug whose drug type has not been determined. The claim recites abstract ideas: “A drug identification apparatus, comprising one or more processors, one or more storage devices, and a computer program that is stored in the storage device and capable of being executed the processor to perform the “detecting” steps, the “creating” step, the “extracting” step, the “determining” step and the “presenting” step are considered being performed by a generic computer. Therefore, If the apparatus, processor and memory are removed from the claim, the method can be easily performed by a human being without the need of any of a computer component. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception. “storing” the identification mark master in a storage device is mere data gathering a high level of generality, and thus are insignificant extra-solution activity. A process that encompass a human performing the steps mentally with or without a physical aid in the form of the “presenting” step, with the “detecting” steps, the “creating” step, the “extracting” step and the “detecting” step being pre-solution acts of processing information which could be performed visually and/or mentally; and A method of organizing human behavior in the form of a social activity of following rules or instructions informing a person to perform the “detecting” steps, the “creating” step, the “extracting” step, the “determining” step and the “presenting” strep. These two abstract ideas will be considered together for analysis as a single abstract idea per MPEP 2106: PNG media_image1.png 468 1527 media_image1.png Greyscale This judicial exception is not integrated into a practical application because there are no recited additional elements that amount to a practical application, such as but no limited to the following as noted in MPEP 2106: PNG media_image2.png 453 1451 media_image2.png Greyscale The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception for the same reason: There are not additional elements other than the abstract idea. Independent claim 13, a processing claim, which recites: A drug identification apparatus comprising: one or more processors; and one or more storage devices, wherein the one or more storage devices are configured to store an identification mark master including an image of an identification mark on each of a front surface and a back surface, for each drug having the identification mark formed by engraving or printing thereon, and wherein the one or more processors are configured to: detect each drug, from a first-surface image acquired by imaging a first surface of a package accommodating drugs in a packaging bag; create, from the identification mark master by using information on a determined drug which is at least one of the drugs, and whose drug type and a front surface and a back surface have been determined based on a drug image extracted for each drug from the first-surface image, a second-surface ground-truth identification mark image list including an identification mark image showing an identification mark of the determined drug appearing on a second surface being a back surface of the first surface of the package; detect each drugs from a second-surface image acquired by imaging the second surface of the package; extract an identification mark of each drug from the second-surface image, and create an extracted identification-mark image list including an extracted identification-mark image for each drug; determine the determined drug in the second-surface image by performing pattern matching using the second-surface ground-truth identification mark image list and the extracted identification-mark image list; and present on the second-surface image, information for differentiating the determined drug from a undetermined drug whose drug type has not been determined. The claim recites abstract ideas: “causing to store” the identification mark master in a storage device is mere data gathering a high level of generality, and thus are insignificant extra-solution activity. A process that encompass a human performing the steps mentally with or without a physical aid in the form of the “presenting” step, with “acquiring” steps, “detecting” steps, “determining” step, the “creating” step, and “detecting” steps being pre-solution acts of processing information which could be performed visually and/or mentally; and A method of organizing human behavior in the form of a social activity of following rules or instructions informing a person to perform the “acquiring” steps, “detecting” steps, “determining” step, “creating” step, and “detecting” steps and “presenting” step. These two abstract ideas will be considered together for analysis as a single abstract idea per MPEP 2106: PNG media_image1.png 468 1527 media_image1.png Greyscale This judicial exception is not integrated into a practical application because there are no recited additional elements that amount to a practical application, such as but no limited to the following as noted in MPEP 2106: PNG media_image2.png 453 1451 media_image2.png Greyscale The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception for the same reason: There are not additional elements other than the abstract idea. Independent claims 1 and 13 are merely a generic computer implementation of the abstract ideas and likewise do not amount to significantly more. See MPEP 2106: PNG media_image3.png 249 1434 media_image3.png Greyscale Likewise, the following dependent claims have been analyzed and do not recite elements that recite a practical application or significantly more and remain rejected under 35 USC 101: Claims 2-12 and 14. Contact Any inquiry concerning this communication or earlier communications from the examiner should be directed to HUO LONG CHEN whose telephone number is (571)270-3759. The examiner can normally be reached on M-F 9am - 5pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Tieu, Benny can be reached on (571) 272-7490. The fax phone number for the organization where this application or proceeding is assigned is (571) 273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HUO LONG CHEN/Primary Examiner, Art Unit 2682
Read full office action

Prosecution Timeline

Dec 22, 2023
Application Filed
Nov 26, 2025
Non-Final Rejection — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12603178
APPARATUS AND METHODS FOR SUPPORTING MEDICAL DECISIONS
2y 5m to grant Granted Apr 14, 2026
Patent 12597162
SYSTEM CALIBRATION USING REMOTE SENSOR DATA
2y 5m to grant Granted Apr 07, 2026
Patent 12592095
METHOD AND SYSTEM OF DETERMINING SHAPE OF A TABLE IN A DOCUMENT
2y 5m to grant Granted Mar 31, 2026
Patent 12586398
Detecting a Homoglyph in a String of Characters
2y 5m to grant Granted Mar 24, 2026
Patent 12567271
PICTURE RECOGNITION METHOD AND APPARATUS, ELECTRONIC DEVICE, AND MEDIUM
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
53%
Grant Probability
84%
With Interview (+30.3%)
3y 2m
Median Time to Grant
Low
PTA Risk
Based on 590 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month